Brightsurf Science News & Current Events

May 17, 2003
KEPPRA international Phase IV SKATE study results show favourable efficacy
First interim results from UCB Pharma's ongoing Phase IV SKATE study show a high proportion of patients with partial onset seizures experienced an overall significant clinical improvement when treated with KEPPRA. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to